|
|
Welcome to BioNews by email, the free weekly news digest of the top stories in assisted conception, genetics, embryo/stem cell research and related areas, published by the Progress Educational Trust. Sent to registered subscribers each week, BioNews by email is aimed at informing debate in these areas by providing balanced and timely summaries of the week's news and developments alongside comment, reviews and recommendations of selected topical conferences, events and more. It also contains job advertisements from the relevant sectors.
Visit the BioNews website at www.bionews.org.uk where you can subscribe for free to receive BioNews by email in one of three formats, plus view more news, comment, reviews and job advertisements and search the full archive.
| Fertility preservation after cancer diagnosis |
| 11 June 2012 - by Valerie Peddie |
| Major professional bodies support the concept of providing every patient of reproductive age with accurate information about the potential risk of impaired fertility after treatment for cancer. In reality, the immediate emphasis is often on treatment, with little time available to discuss options for fertility preservation... [Read More] |
|
| HIV no barrier to parenthood |
| 11 June 2012 - by Catherine Murphy |
| As the UK's largest HIV charity, Terrence Higgins Trust warmly welcomes the decision by the National Institute for Health and Clinical Excellence (NICE) last month to consult on an updated version of its fertility guideline. The new approach outlined by NICE holds the potential to transform fertility services for men and women living with or affected by HIV in the UK who want to become parents... [Read More] |
|
| Human Genetics Commission publish final report |
| 07 June 2012 - by Dr Rebecca Hill |
| The Human Genetics Commission (HGC) has published its final report, which marks the end of its 12 years as an advisory body to the Government... [Read More] |
|
| Pair of gene-targeted melanoma drugs show promise in late-stage clinical trials |
| 11 June 2012 - by Tamara Hirsch |
| Two drugs targeting advanced melanoma linked to a mutation in the BRAF gene are more effective than current chemotherapy at slowing the progress of the skin cancer, clinical trial results indicate... [Read More] |
|
| Whole fetal genome sequenced for the first time |
| 11 June 2012 - by Dr Daniel Grimes |
| Researchers have sequenced the entire genome of an 18 and a half-week-old fetus using DNA samples from the blood of its mother and saliva samples from its father. These findings provide a proof of principle that a fetus can be examined for genetic defects using non-invasive technologies... [Read More] |
|
| Heart disease linked to newly discovered type of stem cell |
| 11 June 2012 - by Dr Rebecca Hill |
| A previously unidentified type of stem cell, usually dormant in blood vessels, is at the heart of vascular disease, according to researchers... [Read More] |
|
| IVF slightly increases risk of adverse outcomes for mother and baby, report says |
| 11 June 2012 - by James Brooks |
| Use of assisted reproductive technologies like IVF carry with them an increased risk of complications for mother and child, a report from the Royal College of Obstetricians and Gynaecologists highlights... [Read More] |
|
| Gene modification helps mouse mum tolerate fetus |
| 11 June 2012 - by Dr Maria Teresa Esposito |
| Immune rejection, the body's defence mechanism, triggered in response to foreign tissues, is a huge problem for transplant operations. But why does a mother's immune system not reject the developing fetus? The answer may lie in modifications to genes that usually activate part of the immune response, according to scientists... [Read More] |
|
| Single genetic tweak allows scientists to transform skin cells into brain cells |
| 11 June 2012 - by Victoria Burchell |
| Skin cells have been transformed into working brain cells thanks to the introduction of a single gene.Previous studies used several genetic factors and chemicals to perform the same feat but scientists in the USA report that just one gene, Sox2, is sufficient... [Read More] |
|
|
